LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 23

Search options

  1. Article ; Online: PPE: producing polluted environment.

    Guzman-Prado, Yuli

    BMJ (Clinical research ed.)

    2021  Volume 375, Page(s) n2822

    MeSH term(s) COVID-19 ; Humans ; Personal Protective Equipment ; SARS-CoV-2
    Language English
    Publishing date 2021-11-18
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.n2822
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Retraction of Studies on Potential Drug Therapies for COVID-19: A Call for Reliability and Scientific Integrity.

    Guzman-Prado, Yuli

    The American journal of cardiology

    2020  Volume 132, Page(s) 173

    MeSH term(s) Antiviral Agents/pharmacology ; Betacoronavirus ; Biomedical Research/methods ; COVID-19 ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Humans ; Journal Impact Factor ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Retraction of Publication as Topic ; SARS-CoV-2
    Chemical Substances Antiviral Agents
    Keywords covid19
    Language English
    Publishing date 2020-06-30
    Publishing country United States
    Document type Letter
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2020.06.061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.

    Guzman-Prado, Yuli

    The American journal of cardiology

    2020  Volume 130, Page(s) 162–163

    MeSH term(s) Betacoronavirus ; COVID-19 ; Chloroquine ; Coronavirus ; Coronavirus Infections/drug therapy ; Humans ; Hydroxychloroquine ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2 ; COVID-19 Drug Treatment
    Chemical Substances Hydroxychloroquine (4QWG6N8QKH) ; Chloroquine (886U3H6UFF)
    Keywords covid19
    Language English
    Publishing date 2020-06-09
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2020.06.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Retraction of Studies on Potential Drug Therapies for COVID-19

    Guzman-Prado, Yuli

    The American Journal of Cardiology

    A Call for Reliability and Scientific Integrity

    2020  Volume 132, Page(s) 173

    Keywords Cardiology and Cardiovascular Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2020.06.061
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19

    Guzman-Prado, Yuli

    The American Journal of Cardiology

    2020  Volume 130, Page(s) 162–163

    Keywords Cardiology and Cardiovascular Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2020.06.003
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Concomitant Use of Levothyroxine and Proton Pump Inhibitors in Patients with Primary Hypothyroidism: a Systematic Review.

    Guzman-Prado, Yuli / Vita, Roberto / Samson, Ondrej

    Journal of general internal medicine

    2021  Volume 36, Issue 6, Page(s) 1726–1733

    Abstract: Background: The aim of this study was to assess the effect of concomitant use of levothyroxine (LT4) and proton pump inhibitors (PPIs) on thyroid-stimulating hormone (TSH) levels in patients with primary hypothyroidism.: Methods: A systematic review ... ...

    Abstract Background: The aim of this study was to assess the effect of concomitant use of levothyroxine (LT4) and proton pump inhibitors (PPIs) on thyroid-stimulating hormone (TSH) levels in patients with primary hypothyroidism.
    Methods: A systematic review of interventional and observational studies that compared the TSH levels before and after concomitant use of LT4 and PPI was performed. Articles published in English up to September 1, 2019, were included. PubMed, EMBASE, and Cochrane Library databases. Gray literature was also searched in repositories, websites OpenGrey and Google Scholar, and abstracts of major international congresses. Study quality was assessed with the Newcastle-Ottawa quality assessment scale for observational studies and the Risk Of Bias In Non-randomized Studies - of Interventions (ROBINS-I) tool was used.
    Results: Five thousand twelve discrete articles were identified. Following assessment and application of eligibility criteria, seven studies were included. There was a considerable heterogeneity among the included studies in design, sample size, inclusion and exclusion criteria, treatment regimen, and baseline demographics. Each of the included studies showed an increase in TSH levels following LT4 and PPI consumption, and in the majority of these, the increase was statistically significant.
    Discussion: The concomitant use of LT4 and PPI showed a significant increase in TSH concentration. However, given the small number of studies, further research is needed to clarify the interfering role of PPI on LT4 intestinal absorption.
    Prospero registration number: CRD42020047084.
    MeSH term(s) Humans ; Hypothyroidism/drug therapy ; Proton Pump Inhibitors ; Thyroxine
    Chemical Substances Proton Pump Inhibitors ; Thyroxine (Q51BO43MG4)
    Language English
    Publishing date 2021-01-19
    Publishing country United States
    Document type Journal Article ; Review ; Systematic Review
    ZDB-ID 639008-0
    ISSN 1525-1497 ; 0884-8734
    ISSN (online) 1525-1497
    ISSN 0884-8734
    DOI 10.1007/s11606-020-06403-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic review.

    Guzman-Prado, Yuli / Ben Shimol, Jennifer / Samson, Ondrej

    Cancer immunology, immunotherapy : CII

    2021  Volume 70, Issue 10, Page(s) 2771–2780

    Abstract: Background: Sarcopenia has been associated with negative clinical outcomes in cancer patients, particularly response to treatment and survival. The exponential growth in the use of immune checkpoint inhibitors (ICIs) has led to an increase in the ... ...

    Abstract Background: Sarcopenia has been associated with negative clinical outcomes in cancer patients, particularly response to treatment and survival. The exponential growth in the use of immune checkpoint inhibitors (ICIs) has led to an increase in the reporting of both adverse events in general (AEs) and immune-related adverse events (irAEs), which are unintended immune-related phenomenon that take place as a result of checkpoint blockade. However, there are no systematic reviews evaluating the relationship between sarcopenia and the risk of developing AEs and irAEs in cancer patients on ICI therapies.
    Methods: PubMed, MEDLINE, Embase, Cochrane and grey literature, repositories, websites Open Grey, Google Scholar, and abstracts of major international congresses were searched up to April 2020 for observational studies on sarcopenia and both AEs and irAEs in patients treated with ICIs. Study quality was assessed with The Newcastle-Ottawa quality assessment scale. PROSPERO registration number: CRD42020197178.
    Results: One hundred and thirteen discrete articles were identified. Seven studies were included after evaluation of the eligibility criteria. Important sources of heterogeneity including the specific cut-points defining sarcopenia, sample size, inclusion and exclusion criteria, treatment regimen, and baseline demographics were evaluated and accounted for accordingly.
    Conclusion: Most of the included studies showed an increased risk of AEs with use of ICIs in cancer patients with sarcopenia, and in the majority of these, the increase was statistically significant. Due to the small number of available studies and the expanding use of ICIs, additional research is warranted.
    MeSH term(s) Adult ; Aged ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Sarcopenia/drug therapy
    Chemical Substances Immune Checkpoint Inhibitors
    Language English
    Publishing date 2021-02-24
    Publishing country Germany
    Document type Journal Article ; Systematic Review
    ZDB-ID 195342-4
    ISSN 1432-0851 ; 0340-7004
    ISSN (online) 1432-0851
    ISSN 0340-7004
    DOI 10.1007/s00262-021-02888-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Developing a toolkit to navigate clinical, educational and research practice during the COVID-19 pandemic.

    Guzman-Prado, Yuli / Vita, Roberto / Ben Shimol, Jennifer

    International journal of clinical practice

    2020  Volume 75, Issue 3, Page(s) e13676

    MeSH term(s) COVID-19 ; Educational Status ; Humans ; Pandemics/prevention & control ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-08-17
    Publishing country India
    Document type Letter
    ZDB-ID 1386246-7
    ISSN 1742-1241 ; 1368-5031
    ISSN (online) 1742-1241
    ISSN 1368-5031
    DOI 10.1111/ijcp.13676
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top